Floatz logo

ARG

Radiation Toxicity

Wake Forest University Health SciencesSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Radiation Toxicity cohort.

Asset / SponsorPhaseRating
FILGRASTIM
IRCCS San Raffaele
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Sun Yat-sen University
Phase 3BB
Amifostine
Alliance for Clinical Trials in Oncology
Phase 3BB
ETOPOSIDE
Sun Yat-sen University
Phase 3BB
Carboplatin
Sun Yat-sen University
Phase 3BB

View all 37 →

Same molecule, other indications

ARG is also rated in:

limb ischemiaDormant
BB
Indicative ·
69 / 100
View asset →
sickle cell diseaseDormant
BB
Indicative ·
69 / 100
View asset →
Hepatitis B Virus InfectionDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →